• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Genen­tech's Gazy­va hits pri­ma­ry end­point in late-stage kid­ney dis­ease tri­al

7 months ago
R&D
Pharma

Up­dat­ed: FDA ad­comm votes to lim­it Op­di­vo, Keytru­da use in stom­ach, esophageal can­cers based on key bio­mark­er

7 months ago
Pharma
FDA+

AGC Bi­o­log­ics to lay off 95 work­ers; Ver­tex taps Lon­za to man­u­fac­ture Cas­gevy

7 months ago
Manufacturing

SIGA is 'deeply an­gered' by for­mer ex­ec's 'i­nac­cu­rate' com­ments about mpox an­tivi­ral

7 months ago
People

Re­pair, Genevant ink deal worth up to $107M; 858 Ther­a­peu­tics rais­es $50M

7 months ago
News Briefing

In­stacart part­ners with 9amHealth to com­bine weight loss drugs with healthy foods

7 months ago
Deals
Health Tech

CSL Se­qirus inks fifth con­tract with BAR­DA, mak­ing the part­ner­ship now worth $1.14B

7 months ago
Deals
Manufacturing

ARCH, biotech's star slug­ger, snags an­oth­er $3B for 13th fund

7 months ago
Financing
Startups

A Parkin­son's drug that Ab­b­Vie ac­quired from Cerev­el suc­ceeds in an­oth­er Phase 3

7 months ago
R&D

Mer­ck, Evax­ion ex­pand col­lab­o­ra­tion with in­fec­tious dis­ease vac­cine pact

7 months ago
Deals
AI

Bio­gen walks away from Sage's es­sen­tial tremor drug af­ter mid-stage flop, pil­l's fu­ture in ques­tion

7 months ago
Deals
R&D

En­Gene un­veils first set of piv­otal da­ta for NMIBC ther­a­py

7 months ago
R&D
Cell/Gene Tx

Flag­ship launch­es start­up to de­sign and make lipid nanopar­ti­cles for ge­net­ic med­i­cines

7 months ago
Financing
Startups

Barcelona VC firm Asabys rais­es sec­ond fund, adding to Eu­rope’s biotech fund­ing scene

7 months ago
Financing
Startups

Next-gen obe­si­ty biotech BioAge Labs to raise $198M in IPO

7 months ago
Financing
Startups

Pfiz­er pulls sick­le cell drug from all mar­kets af­ter da­ta re­view showed rise in deaths and com­pli­ca­tions

7 months ago
Pharma
FDA+

Ex­clu­sive: J&J folds car­dio­vas­cu­lar and meta­bol­ic drug unit

7 months ago
R&D

UK watch­dog crit­i­cizes Mod­er­na for Covid-19 tri­al's use of What­sApp to dan­gle pay­ments to chil­dren

7 months ago
Pharma
Marketing

EMA to dis­cuss Pfiz­er's sick­le cell drug Oxbry­ta af­ter pa­tient deaths

7 months ago
Pharma
FDA+

Bal­ti­more sues Bio­gen, say­ing the com­pa­ny col­lud­ed with PBMs to min­i­mize gener­ic com­pe­ti­tion

7 months ago
Pharma
Law

Emer­gent says it has $400M in or­ders re­lat­ed to mpox out­break 

7 months ago
Pharma
Manufacturing

Celldex re­veals Phase 2 re­spons­es for chron­ic hives drug and high­er rates of neu­trope­nia

7 months ago
R&D

Novo's semaglu­tide shows po­ten­tial in chron­ic skin con­di­tion in obese pa­tients

7 months ago
R&D

Cor­rect­ed: Sanofi inks deal with I-Mab spin­out; Wave dis­clos­es $175M of­fer­ing on heels of DMD da­ta

7 months ago
News Briefing
First page Previous page 90919293949596 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times